Any thoughts as to why the buyback hasn't resumed? Blackout period in Jan and Feb, but highest price paid under the buyback so far is $0.935 (or $0.90 dividend adjusted). Should suggest there's appetite to resume the buyback around these levels.
I understand the business weakness in January and February but it's not like future earnings are impaired as a result. Perhaps looking at an acquisition? Picking up Schramm out of administration?
- Forums
- ASX - By Stock
- Ann: Investor Presentation on 1H23 Results
Any thoughts as to why the buyback hasn't resumed? Blackout...
Featured News
Add DDH (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online